page contents

Tag Archives: Therapeutics

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright Jan 11, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Agile Therapeutics Inc (NASDAQ:AGRX) Today, HC Wainwright reiterated its Buy rating on Agile Therapeutics Inc (NASDAQ:AGRX). There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. The current consensus ...

Read More »

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright Jan 11, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Agile Therapeutics Inc (NASDAQ:AGRX) Today, HC Wainwright reiterated its Buy rating on Agile Therapeutics Inc (NASDAQ:AGRX). There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. The current consensus ...

Read More »

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright Jan 11, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Agile Therapeutics Inc (NASDAQ:AGRX) Today, HC Wainwright reiterated its Buy rating on Agile Therapeutics Inc (NASDAQ:AGRX). There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. The current consensus ...

Read More »

Biotech startup Relay Therapeutics raises $400 million from SoftBank, GV, others

Relay Therapeutics, a biotechnology startup that’s meshing computational power with the latest experimental techniques around “protein motion” to create a cutting-edge drug discovery engine, has raised a whopping $ 400 million in a series C round of funding led by SoftBank’s Vision Fund. Other participants in the round include Alphabet’s GV, Foresite Capital, Perceptive Advisors, Tavistock Group, Casdin Capital, BVF Partners, ...

Read More »

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close